Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. (Q48717671)
Jump to navigation
Jump to search
scientific article published in July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. |
scientific article published in July 2000 |
Statements
1 reference
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group. (English)
1 reference
C Blomqvist
1 reference
A Pluzanska
1 reference
L Hakamies-Blomqvist
1 reference
M Luoma
1 reference
J Sjöström
1 reference
M Sjödin
1 reference
H Mouridsen
1 reference
B Ostenstad
1 reference
I Mjaaland
1 reference
S Ottosson-Lönn
1 reference
J Bergh
1 reference
P Malmström
1 reference
1 July 2000
1 reference
36
1 reference
11
1 reference
1411-1417
1 reference